U.S. Markets open in 2 hrs 53 mins

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
37.77-0.77 (-2.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close38.54
Bid0.00 x 900
Ask0.00 x 1100
Day's Range37.65 - 38.67
52 Week Range23.55 - 40.00
Avg. Volume58,921
Market Cap481.186M
Beta (5Y Monthly)1.19
PE Ratio (TTM)N/A
EPS (TTM)-1.29
Earnings DateMay 07, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est45.00
  • InvestorPlace

    7 Overbought Stocks to Be Very Careful of Right Now

    As September came to a close, the benchmark S&P 500 index was just a few ticks shy of returning 15% since the start of the year. That’s a very solid performance considering the prior year’s remarkable upside response to the novel coronavirus pandemic. At the same time, investors should be concerned about the specter of gambling too heavily on overbought stocks. For one thing, it’s important to realize that even the most revered market experts could be wrong about their projections. Based on imme

  • Business Wire

    ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021

    BAUDETTE, Minn., September 20, 2021--ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Virtual Global Healthcare Conference 2021 as follows:

  • Business Wire

    ANI Pharmaceuticals Announces Launch of Nebivolol Tablets

    BAUDETTE, Minn., September 17, 2021--ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced the launch of Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.